您的购物车当前为空
别名 硝替卡朋
Nitecapone 是一个具有口服活性的、短效的儿茶酚-O-甲基转移酶(COMT)的抑制剂。它具有胃肠道保护和抗氧化活性,能够清除活性氧和一氧化氮,防止脂质过氧化。


为众多的药物研发团队赋能,
让新药发现更简单!
Nitecapone 是一个具有口服活性的、短效的儿茶酚-O-甲基转移酶(COMT)的抑制剂。它具有胃肠道保护和抗氧化活性,能够清除活性氧和一氧化氮,防止脂质过氧化。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 170 | 现货 | |
| 5 mg | ¥ 398 | 现货 | |
| 10 mg | ¥ 648 | 现货 | |
| 25 mg | ¥ 1,070 | 现货 | |
| 50 mg | ¥ 1,600 | 现货 | |
| 100 mg | ¥ 2,370 | 现货 | |
| 200 mg | ¥ 3,380 | 现货 |
Nitecapone 相关产品
| 产品描述 | Nitecapone is a reversible inhibitor of S-COMT (IC50 values of 300 nM in rat liver) |
| 靶点活性 | S-COMT:300 nM |
| 体外活性 | At high micromolar to millimolar concentrations in in vitro research studies, nitecapone is an effective antioxidant, nitric oxide radical scavenger, and iron chelator that can protect cells from lipid peroxidation[1] |
| 体内活性 | After single administration, both?nitecapone?and OR-486 reduced mechanical nociceptive thresholds and thermal nociceptive latencies (hot plate test) at 2 and 3 h, regardless of their brain penetration. These effects were still present after chronic treatment with COMT inhibitors for 5 days. Intraplantar injection of carrageenan reduced nociceptive latencies and both COMT inhibitors potentiated this reduction without modifying inflammation. CGP 28014 shortened paw flick latencies. OR-486 did not modify hot plate times in Comt gene deficient mice. Intrathecal?nitecapone?modified neither thermal nor mechanical nociception[2]. |
| 动物实验 | Used single and repeated administration of a peripherally restricted, short-acting (nitecapone) and also a centrally acting (3,5-dinitrocatechol, OR-486) COMT inhibitor.?We also tested CGP 28014, an indirect inhibitor of COMT enzyme.?Effects of OR-486 on thermal nociception were also studied in COMT deficient mice.?Effects on spinal pathways were assessed in rats given intrathecal nitecapone[2]. |
| 别名 | 硝替卡朋 |
| 分子量 | 265.22 |
| 分子式 | C12H11NO6 |
| CAS No. | 116313-94-1 |
| Smiles | CC(=O)C(=Cc1cc(O)c(O)c(c1)[N+]([O-])=O)C(C)=O |
| 密度 | 1.451 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| 溶解度信息 | DMSO: 2.5 mg/mL (9.43 mM), Sonication is recommended. | |||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (3.77 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||
溶液配制表 | ||||||||||||||||
DMSO
| ||||||||||||||||
评论内容